ORBIMED ADVISORS LLC Q3 2019 Filing
Filed November 14, 2019
Portfolio Value
$5.3B
Holdings
113
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (113 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A S | 3,719,173 | $358.2B | 6797.60% | |
| 2 | 1T7TRICIDA INC | 11,114,280 | $343.1B | 6510.44% | |
| 3 | BSXBOSTON SCIENTIFIC CORP | 5,268,700 | $214.4B | 4068.02% | |
| 4 | ALECALECTOR INC | 12,532,329 | $180.7B | 3429.17% | |
| 5 | —PREVAIL THERAPEUTICS INC | 13,822,463 | $169.7B | 3220.90% | |
| 6 | MRKMERCK & CO INC | 1,954,100 | $164.5B | 3121.39% | |
| 7 | ALXNALEXION PHARMACEUTICALS INC | 1,663,285 | $162.9B | 3091.14% | |
| 8 | SWTXSPRINGWORKS THERAPEUTICS INC | 7,406,307 | $160.6B | 3046.87% | |
| 9 | VRTXVERTEX PHARMACEUTICALS INC | 846,400 | $143.4B | 2721.02% | |
| 10 | NBIXNEUROCRINE BIOSCIENCES INC | 1,575,170 | $141.9B | 2693.36% | |
| 11 | EWEDWARDS LIFESCIENCES CORP | 507,800 | $111.7B | 2118.99% | |
| 12 | ISRGINTUITIVE SURGICAL INC | 205,600 | $111.0B | 2106.47% | |
| 13 | —TURNING POINT THERAPEUTICS I | 2,745,327 | $103.2B | 1958.72% | |
| 14 | TMOTHERMO FISHER SCIENTIFIC INC | 351,900 | $102.5B | 1944.95% | |
| 15 | IOVAIOVANCE BIOTHERAPEUTICS INC | 5,548,326 | $101.0B | 1916.14% | |
| 16 | NTRANATERA INC | 3,000,128 | $98.4B | 1867.26% | |
| 17 | —AVEDRO INC | 4,240,128 | $96.3B | 1826.41% | |
| 18 | INSPINSPIRE MED SYS INC | 1,471,000 | $89.8B | 1703.24% | |
| 19 | —SYNTHORX INC | 5,316,355 | $86.5B | 1641.32% | |
| 20 | NXTCNEXTCURE INC | 2,711,013 | $83.6B | 1587.01% | |
| 21 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 2,460,571 | $83.5B | 1584.68% | |
| 22 | EHTHEHEALTH INC | 1,217,414 | $81.3B | 1542.91% | Call |
| 23 | —WRIGHT MED GROUP N V | 3,837,250 | $79.2B | 1502.14% | |
| 24 | BHCBAUSCH HEALTH COS INC | 3,312,300 | $72.4B | 1373.33% | |
| 25 | —LOGICBIO THERAPEUTICS INC | 6,466,783 | $69.9B | 1326.50% | |
| 26 | EX9EXELIXIS INC | 3,912,900 | $69.2B | 1313.10% | |
| 27 | ABTABBOTT LABS | 822,400 | $68.8B | 1305.70% | |
| 28 | SRPTSAREPTA THERAPEUTICS INC | 887,349 | $66.8B | 1268.23% | Call |
| 29 | PTCTPTC THERAPEUTICS INC | 1,958,900 | $66.3B | 1257.12% | |
| 30 | REGNREGENERON PHARMACEUTICALS | 228,100 | $63.3B | 1200.67% | |
| 31 | ELVANTHEM INC | 254,600 | $61.1B | 1159.95% | |
| 32 | DC4DEXCOM INC | 384,000 | $57.3B | 1087.45% | |
| 33 | MGTXMEIRAGTX HOLDINGS PLC | 3,349,060 | $53.4B | 1013.63% | |
| 34 | HUMHUMANA INC | 181,800 | $46.5B | 882.00% | |
| 35 | —PRINCIPIA BIOPHARMA INC | 1,605,713 | $45.3B | 860.44% | |
| 36 | ARVNARVINAS INC | 2,095,283 | $45.2B | 856.80% | |
| 37 | BLUBELLUS HEALTH INC NEW | 7,025,832 | $45.1B | 856.34% | |
| 38 | —AUDENTES THERAPEUTICS INC | 1,588,069 | $44.6B | 846.48% | |
| 39 | CICIGNA CORP NEW | 291,600 | $44.3B | 839.89% | |
| 40 | —RESTORBIO INC | 4,830,387 | $42.7B | 810.27% | |
| 41 | MRTXEURMIRATI THERAPEUTICS INC | 535,143 | $41.7B | 791.14% | |
| 42 | —MYOKARDIA INC | 783,032 | $40.8B | 774.86% | |
| 43 | ATNXEURATHENEX INC | 3,308,920 | $40.3B | 763.82% | |
| 44 | TNDMTANDEM DIABETES CARE INC | 664,390 | $39.2B | 743.57% | |
| 45 | RAREULTRAGENYX PHARMACEUTICAL IN | 834,313 | $35.7B | 677.27% | |
| 46 | ARGXARGENX SE | 310,400 | $35.4B | 671.22% | |
| 47 | —HARPOON THERAPEUTICS INC | 2,446,409 | $33.4B | 634.12% | |
| 48 | QUREUNIQURE NV | 839,600 | $33.0B | 627.08% | |
| 49 | CRNXCRINETICS PHARMACEUTICALS IN | 2,039,282 | $30.7B | 582.00% | |
| 50 | —ARQULE INC | 3,701,273 | $26.5B | 503.57% | |
| 51 | XTNTXTANT MED HLDGS INC | 9,207,012 | $26.1B | 496.17% | |
| 52 | IQVIQVIA HLDGS INC | 175,000 | $26.1B | 496.06% | |
| 53 | —SPARK THERAPEUTICS INC | 244,900 | $23.8B | 450.67% | |
| 54 | PRTAPROTHENA CORP PLC | 3,022,117 | $23.7B | 449.59% | |
| 55 | AMGNAMGEN INC | 122,100 | $23.6B | 448.35% | |
| 56 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 2,865,524 | $22.0B | 418.14% | |
| 57 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 4,012,969 | $21.9B | 415.01% | |
| 58 | VRCAVERRICA PHARMACEUTICALS INC | 1,479,733 | $21.8B | 414.44% | |
| 59 | —OBSEVA SA | 2,605,531 | $21.7B | 411.84% | |
| 60 | CRSPCRISPR THERAPEUTICS AG | 516,400 | $21.2B | 401.65% | |
| 61 | KRYSKRYSTAL BIOTECH INC | 601,950 | $20.9B | 396.64% | |
| 62 | GILDGILEAD SCIENCES INC | 326,100 | $20.7B | 392.18% | |
| 63 | ALCALCON INC | 351,380 | $20.5B | 388.86% | |
| 64 | CRVSCORVUS PHARMACEUTICALS INC | 6,767,584 | $20.4B | 386.53% | |
| 65 | SCPHSCPHARMACEUTICALS INC | 3,409,865 | $20.0B | 379.81% | |
| 66 | IBBISHARES TR | 200,000 | $19.9B | 377.61% | Put |
| 67 | AUPHAURINIA PHARMACEUTICALS INC | 3,531,002 | $18.9B | 357.80% | |
| 68 | NVONOVO-NORDISK A S | 330,000 | $17.1B | 323.74% | |
| 69 | ZLABZAI LAB LTD | 514,000 | $16.6B | 315.52% | |
| 70 | SVASINOVAC BIOTECH LTD | 2,839,500 | $16.6B | 315.20% | |
| 71 | APLSAPELLIS PHARMACEUTICALS INC | 623,859 | $15.0B | 285.18% | |
| 72 | —FOAMIX PHARMACEUTICALS LTD | 4,788,896 | $14.6B | 276.24% | |
| 73 | NVLSEURALPINE IMMUNE SCIENCES INC | 3,670,955 | $14.5B | 275.85% | |
| 74 | KALAKALA PHARMACEUTICALS INC | 3,447,840 | $13.1B | 248.94% | |
| 75 | TAKTAKEDA PHARMACEUTICAL CO LTD | 750,000 | $12.9B | 244.78% | |
| 76 | RETAEURREATA PHARMACEUTICALS INC | 150,000 | $12.0B | 228.54% | Put |
| 77 | ASNSUSDX4 PHARMACEUTICALS INC | 936,493 | $11.9B | 225.86% | |
| 78 | KPTIEURKARYOPHARM THERAPEUTICS INC | 1,065,900 | $10.3B | 194.57% | |
| 79 | IM8NINSMED INC | 562,300 | $9.9B | 188.22% | |
| 80 | —NABRIVA THERAPEUTICS PLC | 4,644,600 | $9.3B | 176.26% | |
| 81 | —RA PHARMACEUTICALS INC | 376,894 | $8.9B | 169.15% | |
| 82 | PBYIPUMA BIOTECHNOLOGY INC | 786,600 | $8.5B | 160.68% | Call |
| 83 | BIIBBIOGEN INC | 36,200 | $8.4B | 159.93% | |
| 84 | —AVROBIO INC | 570,700 | $8.1B | 152.90% | |
| 85 | SIBNSI BONE INC | 422,000 | $7.5B | 141.50% | |
| 86 | PSNLPERSONALIS INC | 483,842 | $7.1B | 134.73% | |
| 87 | —ALDER BIOPHARMACEUTICALS INC | 350,000 | $6.6B | 125.26% | Put |
| 88 | XENEXENON PHARMACEUTICALS INC | 634,812 | $5.7B | 108.54% | |
| 89 | VRNAVERONA PHARMA PLC | 1,250,396 | $5.7B | 108.43% | |
| 90 | HCATHEALTH CATALYST INC | 179,598 | $5.7B | 107.82% | |
| 91 | —CONSTELLATION PHARMCETICLS I | 835,842 | $5.4B | 102.47% | |
| 92 | SELBUSDSELECTA BIOSCIENCES INC | 2,879,064 | $5.0B | 95.60% | |
| 93 | ARNAEURARENA PHARMACEUTICALS INC | 110,000 | $5.0B | 95.54% | |
| 94 | EPIEURESSA PHARMA INC | 1,471,853 | $5.0B | 94.12% | |
| 95 | —SYNLOGIC INC | 2,029,996 | $4.6B | 88.22% | |
| 96 | NTLAINTELLIA THERAPEUTICS INC | 327,600 | $4.4B | 82.98% | |
| 97 | CTIC1USDCTI BIOPHARMA CORP | 5,000,000 | $4.2B | 79.41% | |
| 98 | —AERPIO PHARMACEUTICALS INC | 5,193,946 | $3.5B | 67.00% | |
| 99 | ACADACADIA PHARMACEUTICALS INC | 96,143 | $3.5B | 65.66% | |
| 100 | AMRNAMARIN CORP PLC | 221,100 | $3.4B | 63.61% |
Page 1 of 2Next